RESUMO
Arsenic is a metalloid element. Acute high-dose exposure to arsenic can cause severe systemic toxicity and death. Lower dose chronic arsenic exposure can result in subacute toxicity that can include peripheral sensorimotor neuropathy, skin eruptions, and hepatotoxicity. Long-term effects of arsenic exposure include an in Due to the physiologic effects of the arsenic on all body systems, thus, chronic arsenic-poisoned patient is a major nursing challenge. The critical care nurse provides valuable assessment and interventions that prevent major multisystem complications from arsenic toxicity
Assuntos
Intoxicação por Arsênico/fisiopatologia , Doença Aguda , Doença Crônica , Poluição Ambiental , Intoxicação por Arsênico/tratamento farmacológico , Literatura de Revisão como AssuntoRESUMO
A study so as to confirm the protective effects of L-ascorbic acid against inorganic arsenic (As23) toxicity was made in male Wistar rats. Multiphase observations made on iAs concentration in target organs viz. liver and kidney, liver function, histopathological changes, ultrastructural alterations, lipid peroxidation, oxidative stress and iAs-DNA interaction strongly favoured its ameliorative effects. These effects could mainly be attributed to its antioxidative property. It offers help in regeneration of GSH and alpha-tocopherol. The chelaticn of iAs by ascorbic acid has also been hypothesized. Inhibition of DNA damage by ascorbic acid in liver and kidney appears to be the most significant part of this study On the basis of these results, we conclude that administration of L-ascorbic acid to arsenic affected population may prevent the occurrence of fatal human diseases.
Assuntos
Alanina Transaminase/sangue , Animais , Antioxidantes/uso terapêutico , Arsênio/sangue , Intoxicação por Arsênico/tratamento farmacológico , Ácido Ascórbico/uso terapêutico , Aspartato Aminotransferases/sangue , Bilirrubina/sangue , Dano ao DNA/efeitos dos fármacos , Glutationa/metabolismo , Dissulfeto de Glutationa/metabolismo , Glutationa Transferase/metabolismo , Rim/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Masculino , Ratos , Ratos WistarRESUMO
Arsenic is a major environmental pollutant and exposure occurs through environmental, occupational and medicinal sources. The contaminated drinking water is the main source of exposure and affected countries are India (West Bengal), Bangladesh, China, Taiwan, Thailand, Chile, Argentina and Romania. Concentrations of arsenic in affected areas are several times higher than the maximum contamination level (MCL) (10 microg/l). Arsenic exposure to human results in degenerative, inflammatory and neoplastic changes of skin, respiratory system, blood, lymphatic system, nervous system and reproductive system. There is no particular remedial action for chronic arsenic poisoning. Low socioeconomic status and malnutrition may increase the risk of chronic toxicity. Early intervention and prevention can give the relief to the affected population.
Assuntos
Animais , Arsênio/farmacocinética , Intoxicação por Arsênico/tratamento farmacológico , Quelantes/uso terapêutico , Terapia por Quelação , Exposição Ambiental/efeitos adversos , Poluentes Ambientais/farmacocinética , Humanos , Pneumopatias/induzido quimicamente , Doenças do Sistema Nervoso Periférico/induzido quimicamente , Dermatopatias/induzido quimicamenteRESUMO
Arsenic is a naturally occurring metalloid, ubiquitously present in the environment in both organic and inorganic forms. Arsenic contamination of groundwater in the West Bengal basin in India is unfolding as one of the worst natural geoenvironmental disaster to date. Chronic exposure of humans to high concentration of arsenic in drinking water is associated with skin lesions, peripheral vascular disease, hypertension, Blackfoot disease and high risk of cancer The underlying mechanism of toxicity includes the interaction with the sulphydryl groups and the generation of reactive oxygen species leading to oxidative stress. Chelation therapy with chelating agents like British Anti Lewisite (BAL), sodium 2,3-dimercaptopropane 1-sulfonate (DMPS), meso 2,3 dimercaptosuccinic acid (DMSA) etc., is considered to be the best known treatment against arsenic poisoning. The treatment with these chelating agents however is compromised with certain serious drawbacks/side effects. The studies show that supplementation of antioxidants along with a chelating agent prove to be a better treatment regimen. This review attempts to provide the readers with a comprehensive account of recent developments in the research on arsenic poisoning particularly the role of oxidative stress/free radicals in the toxic manifestation, an update about the recent strategies for the treatment with chelating agents and a possible beneficial role of antioxidants supplementation to achieve the optimum effects.
Assuntos
Acetilcisteína/uso terapêutico , Animais , Antioxidantes/uso terapêutico , Intoxicação por Arsênico/tratamento farmacológico , Ácido Ascórbico/uso terapêutico , Quelantes/uso terapêutico , Terapia por Quelação , Dimercaprol/uso terapêutico , Quimioterapia Combinada , Poluentes Ambientais/intoxicação , Humanos , Melatonina/uso terapêutico , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/uso terapêutico , Selênio/uso terapêutico , Succímero/análogos & derivados , Taurina/uso terapêutico , Ácido Tióctico/uso terapêutico , Vitamina E/uso terapêutico , Zinco/uso terapêuticoRESUMO
Arsenic is an odorless, colorless and tasteless element long linked with effects on the skin and viscera. Exposure to it may be cryptic. Although human intake can occur from four forms, elemental, inorganic (trivalent and pentavalent arsenic) and organic arsenic, the trivalent inorganic arsenicals constitute the major human hazard. Arsenic usually reaches the skin from occupational, therapeutic, or environmental exposure, although it still may be employed as a poison. Occupations involving new technologies are not exempt from arsenic exposure. Its acute and chronic effects are noteworthy. Treatment options exist for arsenic-induced pathology, but prevention of toxicity remains the main focus. Vitamin and mineral supplementation may play a role in the treatment of arsenic toxicity.